Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2

FEBS Letters

Volumn 579, Issue 9, 2005, Pages 1945-1950

  Kirchhofer, Daniel ^a   Peek, Mark ^a   Lipari, Michael T ^a   Billeci, Karen ^a   Fan, Bin ^a   Moran, Paul ^a  

^a GENENTECH INC   (United States)

Author keywords

Hepatocyte growth factor; Hepsin; HGFA inhibitor 1; HGFA inhibitor 2; Kunitz domain; Prostate cancer

Indexed keywords

HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 1B; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 2; HEPSIN; ISOENZYME; SCATTER FACTOR; SERINE PROTEINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 15544386767     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.01.085     Document Type: Article

References (38)

1. R. Szabo, Q. Wu, R.B. Dickson, S. Netzel-Arnett, T.M. Antalis, and T.H. Bugge Type II transmembrane serine proteases Thromb. Haemost. 90 2003 185 193
2. S.P. Leytus, K.R. Loeb, F.S. Hagen, K. Kurachi, and E.W. Davie A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by liver and hepatoma cells Biochemistry 27 1988 1067 1074
3. T.-K.H. Vu, R.W. Liu, C.J. Haaksma, J.J. Tomasek, and E.W. Howard Identification and cloning of the membrane-associated serine protease, hepsin, from mouse preimplantation embryos J. Biol. Chem. 272 1997 31315 31320
4. Y. Kazama, T. Hamamoto, D.C. Foster, and W. Kisiel Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation J. Biol. Chem. 270 1995 66 72
5. Q. Wu, D. Yu, J. Post, M. Halks-Miller, J.E. Sadler, and J. Morser Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease J. Clin. Invest. 101 1998 321 326
6. L.R. Zacharski, D.L. Ornstein, V.A. Memoli, S.M. Rousseau, and W. Kisiel Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma Thromb. Haemost. 79 1998 876 877
7. A. Torres-Rosado, K.S. O'Shea, A. Tsuji, S.-H. Chou, and K. Kurachi Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth Proc. Natl. Acad. Sci. USA 90 1993 7181 7185
8. V. Srikantan, M. Valladares, J.S. Rhim, J.W. Moul, and S. Srivastava HEPSIN inhibits cell growth/invasion in prostate cancer cells Cancer Res. 62 2002 6812 6816
9. H. Tanimoto, Y. Yan, J. Clarke, S. Korourian, K. Shigemasa, T.H. Parmley, G.P. Parham, and T.J. O'Brien Hepsin, a cell surface protease identified in hepatoma cells, is overexpressed in ovarian cancer Cancer Res. 57 1997 2884 2887
10. J.B. Welsh, L.M. Sapinoso, A.I. Su, S.G. Kern, J. Wang-Rodriguez, C.A. Moskaluk, H.F. Frierson Jr., and G.M. Hampton Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer Cancer Res. 61 2001 5974 5978
11. T.A. Stamey, J.A. Warrington, M.C. Caldwell, Z. Chen, Z. Fan, M. Mahadevappa, J.E. McNeal, R. Nolley, and Z. Zhang Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia J. Urol. 166 2001 2171 2177
12. J.A. Magee, T. Araki, S. Patil, T. Ehrig, L. True, P.A. Humphrey, W.J. Catalona, M.A. Watson, and J. Milbrandt Expression profiling reveals hepsin overexpression in prostate cancer Cancer Res. 61 2001 5692 5696
13. S.M. Dhanasekaran, T.R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K.J. Pienta, M.A. Rubin, and A.M. Chinnaiyan Delineation of prognostic biomarkers in prostate cancer Nature 412 2001 822 826
14. J. Luo, D.J. Duggan, Y. Chen, J. Sauvageot, C.M. Ewing, M.L. Bittner, J.M. Trent, and W.B. Isaacs Human prostate cancer and benign prostate hyperplasia: molecular dissection by gene expression profiling Cancer Res. 61 2001 4683 4688
15. C. Stephan, G.M. Yousef, A. Scorilas, K. Jung, M. Jung, G. Kristiansen, S. Hauptmann, T. Kishi, T. Nakamura, S.A. Loening, and E.P. Diamandis Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer J. Urol. 171 2004 187 191
16. O. Klezovitch, J. Chevillet, J. Mirosevich, R.L. Roberts, R.J. Matusik, and V. Vasioukhin Hepsin promotes prostate cancer progression and metastasis Cancer Cell 6 2004 185 195
17. C.-Y. Lin, J. Anders, M. Johnson, Q.A. Sang, and R.B. Dickson Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity J. Biol. Chem. 274 1999 18231 18236
18. T. Takeuchi, M.A. Shuman, and C.S. Craik Reverse biochemistry: Use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue Proc. Natl. Acad. Sci. USA 96 1999 11054 11061
19. C. Birchmeier, W. Birchmeier, E. Gherardi, and G.F. Vande Woude Met, metastasis, motility and more Nat. Rev. Mol. Cell Biol. 4 2003 915 925
20. K. Miyazawa, T. Shimomura, A. Kitamura, J. Kondo, Y. Morimoto, and N. Kitamura Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor J. Biol. Chem. 268 1993 10024 10028
21. S.-L. Lee, R.B. Dickson, and C.-Y. Lin Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease J. Biol. Chem. 275 2000 36720 36725
22. D. Kirchhofer, M. Peek, W. Li, J. Stamos, C. Eigenbrot, S. Kadkhodayan, J.M. Elliott, R.T. Corpuz, R.A. Lazarus, and P. Moran Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1 J. Biol. Chem. 278 2003 36341 36349
23. T. Shimomura, K. Denda, A. Kitamura, T. Kawaguchi, M. Kito, J. Kondo, S. Kagaya, L. Qin, H. Takata, K. Miyazawa, and N. Kitamura Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor J. Biol. Chem. 272 1997 6370 6376
24. C.-Y. Lin, J. Anders, M. Johnson, and R.B. Dickson Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk J. Biol. Chem. 274 1999 18237 18242
25. T. Kawaguchi, L. Qin, T. Shimomura, J. Kondo, K. Matsumoto, K. Denda, and N. Kitamura Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor J. Biol. Chem. 272 1997 27558 27564
26. K.A. Delaria, D.K. Muller, C.W. Marlor, J.E. Brown, R.C. Das, S.O. Roczniak, and P.P. Tamburini Characterization of placental bikunin, a novel human serine protease inhibitor J. Biol. Chem. 272 1997 12209 12214
27. D. Kirchhofer, X. Yao, M. Peek, C. Eigenbrot, M.T. Lipari, K.L. Billeci, H.R. Maun, P. Moran, L. Santell, C. Wiesmann, and R.A. Lazarus Structural and functional basis of the serine protease-like HGF β-chain in Met binding and signalling J. Biol. Chem. 279 2004 39915 39924
28. M. Peek, P. Moran, N. Mendoza, D. Wickramasinghe, and D. Kirchhofer Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa J. Biol. Chem. 277 2002 47804 47809
29. P.A. Humphrey, X. Zhu, R. Zarnegar, P.E. Swanson, R.T. Ratliff, R.T. Vollmer, and M.L. Day Hepatocyte growth factor and its receptor (c-Met) in prostatic carcinoma Am. J. Pathol. 147 1995 386 396
30. A.S.T. Wong, S.L. Pelech, M.M.M. Woo, G. Yim, B. Rosen, T. Ehlen, P.C.K. Leung, and N. Auersperg Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis? Oncogene 20 2001 1318 1328
31. M.D. Oberst, C.A. Williams, R.B. Dickinson, M.D. Johnson, and C.-Y. Lin The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor J. Biol. Chem. 278 2003 26773 26779
32. T. Takeuchi, J.L. Harris, W. Huang, K.W. Yan, S.R. Coughlin, and C.S. Craik Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates J. Biol. Chem. 275 2000 26333 26342
33. M.S. Pepper, K. Matsumoto, T. Nakamura, L. Orci, and R. Montesano Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells J. Biol. Chem. 1992 20493 20496
34. C.L. Hall, R. Tsan, G. Mugnai, A. Mazar, R. Radinsky, and C.A. Pettaway Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA) Prostate 59 2004 167 176
35. G. Davies, W.G. Jiang, and M.D. Mason Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion Clin. Cancer Res. 7 2001 3289 3297
36. H. Kataoka, T. Suganuma, T. Shimomura, H. Itoh, N. Kitamura, K. Nabeshima, and M. Koono Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues: cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues J. Histochem. Cytochem. 47 1999 673 682
37. M.D. Oberst, M.D. Johnson, R.B. Dickson, C.-Y. Lin, B. Singh, M. Stewart, A. Williams, A. al-Nafussi, J.F. Smyth, H. Gabra, and G.C. Sellar Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters Clin. Cancer Res. 8 2002 1101 1107
38. M. Yamauchi, H. Kataoka, H. Itoh, T. Seguchi, Y. Hasui, and Y. Osada Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma J. Urol. 171 2004 890 896